The Global Biopsy Devices Market Size is projected to grow at a CAGR of 8.09% during the forecast period from 2025 to 2032 | DelveInsight

DelveInsight's Biopsy Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Biopsy Devices companies' market shares, challenges, Biopsy Devices Market Drivers, barriers, trends, and key market Biopsy Devices companies in the market.

To read more about the latest highlights related to the Biopsy Devices Market @ https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Key Takeaways from the Biopsy Devices Market Report

* In July 2025, Selio Medical earned FDA clearance for its Pre-B. Seal device, the first of its kind to reduce post-lung biopsy pneumothorax by pre-sealing the biopsy site, improving safety and enabling same-day patient discharge. Strategic significance: Addresses a common lung biopsy complication and supports the shift toward outpatient procedures.
* In July 2025, Mendaera secured FDA clearance for its handheld robotic needle delivery system, designed to enhance precision in fine-needle aspiration biopsies, among other minimally invasive procedures. Strategic significance: Brings robotic precision to a widely used, traditionally manual biopsy technique.
* In January 2025, Biobot Surgical's Mona Lisa 2.0 robotic system, designed for prostate biopsy and ablation, obtained CE certification, integrating real-time needle trajectory adjustments to enhance precision and reduce tissue injury risk. Strategic significance: Advances robotic-assisted precision in prostate biopsy, a high-volume diagnostic procedure.
* The Biopsy Devices market is expected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, reflecting strong and sustained growth.
* The global Biopsy Devices market is growing at a CAGR of 8.09% during the forecast period from 2025 to 2032.
* The principal drivers are increasing cancer incidence and chronic disease burden, including breast, lung, prostate, and colorectal cancer; increasing demand for minimally invasive procedures; increasing technological advancements in devices; and an increase in product development activities among key market players.
* The leading Biopsy Devices Companies include Boston Scientific Corporation, Cardinal Health, Medtronic, BD, Cook, Devicor Medical Products Inc., B. Braun Melsungen AG, ARGON MEDICAL, OLYMPUS CORPORATION, and FUJIFILM, among others.

To know more about why North America is leading the market growth in the Biopsy Devices Market, Get a snapshot @ https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Biopsy Devices Overview

Biopsy devices are specialized medical instruments used to extract tissue or cell samples from a patient's body for laboratory examination. Their primary purpose is to diagnose diseases, most notably cancer, but they are also used to investigate infections, inflammation, and immune disorders. The market spans needle-based biopsy instruments, biopsy guidance systems, robotic biopsy devices, and biopsy accessories, used across breast, lung, colorectal, and prostate biopsy applications in hospitals, diagnostic & imaging centers, and other care settings.

Biopsy Devices Market Key Growth Drivers

* Increasing cancer incidence and chronic diseases are the primary driver, with DelveInsight estimating approximately 102,000 incident cases of triple-negative breast cancer in the 7MM in 2023, and global breast cancer incidence reaching 2,296,841 cases in 2022, projected to reach 3,364,291 cases by 2045.
* Increasing demand for minimally invasive procedures is escalating the market, as patients and providers seek options with reduced pain, shorter recovery time, and greater accuracy, boosting adoption of needle-based, image-guided, and vacuum-assisted biopsy techniques.
* Increasing technological advancements, including vacuum-assisted systems, image-guided techniques, robotic-assisted procedures, and liquid biopsy innovations, are enhancing diagnostic accuracy, speed, and patient safety.

Get a sneak peek at the Biopsy Devices Market Dynamics @ https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Biopsy Devices Market Segment Analysis

The Biopsy Devices Market by Product Type (Needle-based Biopsy Instruments, Biopsy Guidance Systems, Robotic Biopsy Devices, and Biopsy Accessories), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), End-User (Hospitals, Diagnostic & Imaging Centers, and Others), and Geography.

By product type, needle-based biopsy instruments are anticipated to dominate with around 39% share in 2024, as core needle, fine-needle aspiration, and vacuum-assisted biopsy needles remain the most widely adopted and trusted method for tissue sampling given their minimally invasive nature and high diagnostic accuracy. By application, breast biopsy is anticipated to dominate with around 30% share in 2024, driven by the rising global incidence of breast cancer and breast biopsy's role as the gold standard for confirming diagnosis after abnormal mammography or ultrasound findings. By end-user, hospitals are expected to hold the largest share in 2024 due to the high volume of diagnostic procedures performed and the availability of advanced imaging and biopsy technologies. North America is projected to dominate with approximately 41% share in 2024, while Asia-Pacific is emerging as a major growth driver.

Which MedTech key players in the Biopsy Devices Market are set to emerge as the trendsetter explore @ https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Biopsy Devices Market Competitive Landscape

The competitive landscape of the Biopsy Devices market is characterized by moderate to high concentration, with a few global players such as Becton Dickinson, Hologic, Boston Scientific, Devicor, and Cook Medical holding significant market shares. These companies compete on innovation, product portfolios, and global reach, often focusing on technological advancements like vacuum-assisted and image-guided systems, while regional and niche players gain traction by offering cost-effective solutions in emerging markets.

Biopsy Devices Companies

Boston Scientific Corporation, Cardinal Health, Medtronic, BD, Cook, Devicor Medical Products Inc., B. Braun Melsungen AG, ARGON MEDICAL, OLYMPUS CORPORATION, FUJIFILM Corporation, INRAD Inc., Hologic Inc., C. R. Bard, Dr. Japan Co. Ltd., Limaca-medical, Owlstone Medical Ltd., Zamar Care, KOELIS, ST. STONE MEDICAL DEVICES PVT LTD, Iscon Surgicals Ltd., and others.

Biopsy Devices Market Restraints

Despite strong growth drivers, the Biopsy Devices market faces several restraints. The high cost of advanced devices, such as image-guided and robot-assisted systems, limits affordability and accessibility, particularly for smaller healthcare facilities and in emerging economies. The risk of complications and patient anxiety, including concerns about bleeding and tissue trauma, can hinder adoption. The market is also constrained by stringent regulatory processes that are time-consuming and expensive, delaying product launches and stifling innovation, especially for startups. Growing competition from alternative diagnostic methods, such as liquid biopsies and advanced imaging, poses a long-term challenge to the traditional tissue biopsy segment, and a shortage of skilled professionals trained to use complex devices creates a bottleneck impeding widespread technology adoption.

Interested in knowing the Biopsy Devices Market by 2032? Click to get a snapshot of the Biopsy Devices Market Trends- https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Scope of the Biopsy Devices Market Report

* Coverage- Global
* Forecast Period- 2025-2032
* Biopsy Devices Companies- Boston Scientific Corporation, Cardinal Health, Medtronic, BD, Cook, Devicor Medical Products Inc., B. Braun Melsungen AG, ARGON MEDICAL, OLYMPUS CORPORATION, FUJIFILM, and others.
* Biopsy Devices Market Restraints and Regulatory Analysis
* Biopsy Devices Porter Five Forces Analysis and Market Assessment

Explore more information of the Biopsy Devices Market Insights @ https://www.delveinsight.com/report-store/biopsy-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Table of Contents

1. Biopsy Devices Market Report Introduction
2. Biopsy Devices Market Executive Summary
3. Biopsy Devices Market Key Factors Analysis
4. Impact Analysis
5. Regulatory Analysis
6. Biopsy Devices Market Porter's Five Forces Analysis
7. Biopsy Devices Market Assessment
8. Competitive Landscape
9. Startup Funding & Investment Trends
10. Biopsy Devices Market Company and Product Profiles
11. KOL Views
12. Project Approach
13. About DelveInsight
14. Disclaimer & Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.